Literature DB >> 1387412

Human dermal fibroblast interleukin-1 receptor antagonist (IL-1ra) and interleukin-1 beta (IL-1 beta) mRNA and protein are co-stimulated by phorbol ester: implication for a homeostatic mechanism.

L S Chan1, C Hammerberg, K Kang, P Sabb, A Tavakkol, K D Cooper.   

Abstract

Although the major functions of fibroblasts are to produce extracellular matrix and to maintain a structural framework for organ systems, recent studies have demonstrated that fibroblasts are active participants in inflammatory processes by synthesizing various inflammatory mediators. In this report, we provide evidence that fibroblasts may contribute to the regulation of inflammation by the synthesis of both the intracellular form and the secretory form of interleukin-1 receptor antagonists in conjunction with interleukin-1 beta production. Indirect immunofluorescence microscopy localized interleukin-1 receptor antagonist and interleukin-1 beta proteins primarily in the fibroblast cytoplasm. Polymerase chain reaction amplification of reverse-transcribed mRNA with primers specific for the intracellular form of interleukin-1 receptor antagonist detected cDNA fragments present in both unstimulated and phorbol ester-stimulated fibroblasts, identical in molecular size to that in unstimulated keratinocytes. Amplification with primers specific for the secretory form of interleukin-1 receptor antagonist, however, detected cDNA fragments in phorbol ester-stimulated fibroblasts and phytohemagglutinin-stimulated peripheral mononuclear cells, but not in unstimulated fibroblasts or keratinocytes. The amplified fibroblast cDNA sequences for both intracellular and secretory interleukin-1 receptor antagonists were confirmed by digestion with three restriction endonucleases. By ethidium bromide visualization of amplified cDNA derived from serially diluted total cellular RNA and by Southern blot hybridization analysis of amplified cDNA, we have demonstrated that fibroblast interleukin-1 receptor antagonist mRNA and interleukin-1 beta mRNA were co-stimulated by phorbol ester. Similarly, ELISA demonstrated that fibroblast cytoplasmic interleukin-1 receptor antagonist protein and interleukin-1 beta protein were co-stimulated by phorbol ester. Our data suggests that the intracellular form of interleukin-1 receptor antagonist may be important in maintaining physiologic homeostasis in fibroblasts during interleukin-1 beta induction and release.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1387412     DOI: 10.1111/1523-1747.ep12616653

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

1.  Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model.

Authors:  L Chen; O Martinez; L Overbergh; C Mathieu; B S Prabhakar; L S Chan
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

2.  Expression of eotaxin, an eosinophil-selective chemokine, parallels eosinophil accumulation in the vesiculobullous stage of incontinentia pigmenti.

Authors:  S Jean-Baptiste; E A O'Toole; M Chen; J Guitart; A Paller; L S Chan
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

3.  Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis.

Authors:  F W Tam; J Smith; S J Cashman; Y Wang; E M Thompson; A J Rees
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

4.  Role of fibroblasts in the regulation of proinflammatory interleukin IL-1, IL-6 and IL-8 levels induced by keratinocyte-derived IL-1.

Authors:  I L Boxman; C Ruwhof; O C Boerman; C W Löwik; M Ponec
Journal:  Arch Dermatol Res       Date:  1996-06       Impact factor: 3.017

5.  Novel production of interleukin-1 receptor antagonist peptides in normal human cornea.

Authors:  M C Kennedy; J T Rosenbaum; J Brown; S R Planck; X Huang; C A Armstrong; J C Ansel
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

6.  Interleukin 1 (IL-1) and IL-1-receptor antagonist (IL-1-RA) in middle ear cholesteatoma: an analysis of protein production and biological activity.

Authors:  J Bujía; C Kim; P Ostos; H Sudhoff; E Kastenbauer; L Hültner
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

7.  Combined Analysis of IFN-γ, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection.

Authors:  Maho Suzukawa; Shunsuke Akashi; Hideaki Nagai; Hiroyuki Nagase; Hiroyuki Nakamura; Hirotoshi Matsui; Akira Hebisawa; Ken Ohta
Journal:  PLoS One       Date:  2016-04-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.